NCT00093899已完成3 期
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 611
- 主要终点
- Plasma LDL-C.
研究概览
简要总结
The purpose of this study is to assess the cholesterol lowering effects of an investigational drug in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 79 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women 18-79 years of age with high cholesterol and high triglycerides.
排除标准
- •Individuals who do not meet specific cholesterol or triglyceride levels as required by the study.
结局指标
主要结局
Plasma LDL-C.
次要结局
- Plasma HDL-C, non-HDL-C, and TG. Tolerability
研究者
相似试验
终止
3 期
Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With HypercholesterolemiaHypercholesterolemiaNCT00532558Takeda657
招募中
不适用
Study for evaluation of cholesterol lowering effect, dose and safety of Bifidobacterium breve IDCC 4401KCT0003040Ildong pharmaceutical66
已完成
3 期
A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)HypercholesterolemiaNCT00132717Organon and Co450
已完成
4 期
Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.ST-Segment Elevation Myocardial InfarctionNCT01385631Odense University Hospital87
已完成
1 期
A study to see if Green tea (Camellia Sinensis 3x) can lower the cholesterol levelCTRI/2019/01/016860Father Muller Research Centre40